Veeda Clinical
Research is the first CRO to establish a
specialized renal clinical pharmacology unit
in India. Veeda’s unit is based in the 140
bed single speciality urological hospital
providing access to a full spectrum of
patients with impaired kidney function from
mild to the most severe. The Unit has six
fully monitored beds, is staffed by Veeda’s
own personnel, and is equipped with all of
the supporting facilities necessary for the
safe conduct of clinical trials in this
special population.
Hospital Location
Veeda’s renal clinical pharmacology unit is
based in the renowned Muljibhai Patel
Urological Hospital (MPUH) in Nadiad, India.
The MPUH has established itself as the
centre of excellence in India for the
treatment of urological disorders, as well
as being a world leader in teaching and
research in this therapeutic area.
Established as a charitable trust, the
MPUH’s 40 physicians, 70 nurses, 60
technicians, 150 support staff provide
world-class kidney care to all patients
requiring treatment. The hospital has state
of the art diagnostic and laparoscopic
operating capability with specialisation in
the treatment of kidney stones, prostate
surgery, dialysis, kidney transplant, uro-oncology,
female & paediatric urology.
MPUH is recognised internationally as a
teaching and research centre and is
currently participating in around 175
research and clinical studies, many in
collaboration with international partners.
Rapid access to Patients
Every year the MPUH performs over 3,000
operations, 100 transplants and 12,000
dialyses. Veeda’s location in the MPUH
itself provides direct access to the
hospital’s data base of over 5,000 patients
allowing rapid recruitment of a full range
of patients with mild, moderate and severe
renal impairment. The MPUH sees between 60
and 80 dialysis patients per month, giving
ready availability of even dialysed
patients. On average, it takes around one
month to complete a typical study in renal
impaired subjects (assuming 6 each of mild,
moderate and severely impaired subjects).
Regulatory process
Studies in renal patients are treated
identically to studies in healthy volunteers
from a regulatory perspective. In order to
commence a study, approval must be granted
by the Drugs Controller General of India
(DCGI). The process for obtaining DCGI
approval is very similar to that in the
West. Veeda is able to assist with all
aspects of the regulatory and ethics
submissions.
To know more about Veeda services or if you have any query please click here to contact us
To know more how veeda’s expertise and experience for Renal Clinical Research can help you, please be in touch with us using this form
